PlainRecalls

Boothwyn Pharmacy LLC

Compiled from official public sources by the publisher.

4 recalls on record · Latest: Sep 10, 2025

Subscribe to new Boothwyn Pharmacy LLC recalls (RSS)

Agency notice ledger

Federal filing book Boothwyn Pharmacy LLC LIGHT-BOOK · SINGLE-AGENCY

#2,808 of 14,151 · 4 notices · 0.004% archive

  • BOOK 4 notices
  • RANK #2,808 of 14,151
  • SHARE 0.004% archive
  • AGENCY FDA Drug (4)
  • CAT drugs
  • CATS 1 category
  • LATEST Sep 10, 2025
  • PHOTO 1 Epic, LLC

Nearest notice-volume peer: 1 Epic, LLC (0 notice gap)

Boothwyn Pharmacy LLC accounts for about 0.004% of the 104,423-notice archive on 4 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Where Boothwyn Pharmacy LLC sits among 14,151 recalling firms

Boothwyn Pharmacy LLC ranks 2,808th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Boothwyn Pharmacy LLC vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

4 2808th of 14151 higher than 10,859 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-14

Boothwyn Pharmacy LLC in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Boothwyn Pharmacy LLC holds about 0.004% of archive notices alongside 4 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Sep 10, 2025

Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy
FDA Drug Low Sep 10, 2025

Fluorescein 2% Ophth, 3 ML, Boothwyn Pharmacy, 800-476-7496
FDA Drug Moderate Sep 10, 2025

Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy
FDA Drug Moderate Sep 10, 2025

Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy

Boothwyn Pharmacy LLC is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (4 here).

1 Epic, LLC 4 3rd Day Beverages LLC 4 Aaa Pharmaceutical, Inc. 4 Aap Implantate Ag 4 Ab Sciex, LLC 4

Similar drugs volume

Nearest multi-notice firms in the same narrow category lane.

Aaa Pharmaceutical, Inc. 4 Advanced Accelerator Applications USA, Inc. 4 Alkermes Inc 4 Allergan 4

Frequently Asked Questions

How many federal recall notices name Boothwyn Pharmacy LLC? ▼
PlainRecalls indexes 4 distinct federal recall events naming Boothwyn Pharmacy LLC, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Boothwyn Pharmacy LLC sit among other recalling firms? ▼
Boothwyn Pharmacy LLC ranks #2,808 of 14,151 by distinct recall-event count among 14,151 firms in this archive (77th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Boothwyn Pharmacy LLC's notices? ▼
FDA Drug accounts for 4 of this firm's 4 indexed notices.
What product category dominates Boothwyn Pharmacy LLC's filing book? ▼
Filings for Boothwyn Pharmacy LLC span 1 product category, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Boothwyn Pharmacy LLC: 4 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Boothwyn Pharmacy LLC; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026